CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
TOTAL REVENUE	$ 17,851	$ 17,959	$ 43,622	$ 35,181
COST OF GOODS SOLD	(8,324)	(8,375)	(22,374)	(20,433)
RESEARCH AND DEVELOPMENT EXPENSES	(4,467)	(2,998)	(13,934)	(8,846)
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES	(2,929)	(2,595)	(8,156)	(9,194)
OPERATING INCOME (LOSS)	2,131	3,991	(842)	(3,292)
FINANCIAL EXPENSES	(180)	(299)	(808)	(1,056)
FINANCIAL INCOME	288	151	818	1,186
FINANCIAL INCOME (EXPENSES), NET	108	(148)	10	130
INCOME (LOSS) BEFORE TAXES ON INCOME	2,239	3,843	(832)	(3,162)
TAXES ON INCOME (TAX BENEFIT)	(116)	607	268	400
NET INCOME (LOSS)	$ 2,355	$ 3,236	$ (1,100)	$ (3,562)
EARNINGS (LOSS) PER SHARE OF COMMON STOCK - BASIC (in dollars per share)	$ 0.03	$ 0.04	$ (0.01)	$ (0.05)
EARNINGS (LOSS) PER SHARE OF COMMON STOCK - DILUTED (in dollars per share)	$ 0.03	$ 0.03	$ (0.01)	$ (0.05)
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING EARNINGS (LOSS) PER SHARE - BASIC (in shares)	79,281,685	73,549,745	78,225,112	73,301,091
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING EARNINGS (LOSS) PER SHARE - DILUTED (in shares)	80,814,564	81,217,068	78,225,112	73,301,091
Goods
TOTAL REVENUE	$ 17,673	$ 17,839	$ 43,108	$ 34,820
License and R&D Services
TOTAL REVENUE	$ 178	$ 120	$ 514	$ 361